Aarey Drugs & Pharmaceuticals (BOM:524412) FFO


BOM:524412 Aarey Drugs & Pharmaceuticals Ltd BOM:524412
61 GF Score
Price ₹87.70
GF Value ₹58.29
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Aarey Drugs & Pharmaceuticals FFO?

FFO (Funds from operations) only applies to REITs.

BOM:524412
61GF Score
Aarey Drugs & Pharmaceuticals Ltd BOM:524412
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Aarey Drugs & Pharmaceuticals (BOM:524412) Overvalued in 2026?

Based on GuruFocus' analysis, Aarey Drugs & Pharmaceuticals stock appears to be overvalued. The current stock price of ₹87.70 is trading 50.5% above its estimated GF Value™ of ₹58.29. GuruFocus considers Aarey Drugs & Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for BOM:524412:

  • FFO:
  • GF Value™: ₹58.29 vs. price of ₹87.70 (50.5% above fair value)
  • GF Score™: 61/100 with 2 warning signs

No single metric tells the full story. See the BOM:524412 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Aarey Drugs & Pharmaceuticals Business Description

Other Exchanges AAREYDRUGS:India
Address 340/348, Narshi Natha Street, 107, Sahakar Bhavan, Masjid Bunder, Mumbai, MH, IND, 400 009
Aarey Drugs & Pharmaceuticals Ltd is engaged in bulk drug manufacturing and offers products for industrial applications. The company manufactures active pharmaceutical ingredients, intermediates, and specialty chemicals. It is also involved in the trading of industrial solvents and chemicals. The products offered by the company include N-Methyl urea, Dimethyl urea, Mefenamic acid, Metformin, Doxaphylline, and BMD among others. The company principally carries out its business operations in India.
61GF Score

Get the complete analysis for BOM:524412

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹87.70
Price
₹58.29
GF Value